Clinical Trials Logo

Filter by:
NCT ID: NCT04888962 Completed - Pregnancy Related Clinical Trials

Quantitative Sensory Psychophysical Correlates of Pain in Pregnant Women With OUD

Q-PRONTO
Start date: June 14, 2021
Phase:
Study type: Observational

This is a prospective observational case-control study comparing quantitative sensory testing data preformed during the third trimester of pregnancy and within 24 hours postpartum in women on medication-assisted treatment for opioid use disorder (OUD) to a gestational age-controlled cohort of women who do not have OUD. The primary goal is to measure elements of quantitative sensory testing including temperature pain threshold, temperature pain tolerance, and thermal and mechanical temporal summation for patients with opioid use disorder on medication-assisted treatment (MAT), and compare these results to gestational age matched controlled pregnant patients not on MAT.

NCT ID: NCT04888637 Completed - Epilepsy Clinical Trials

Pediatric Language and Memory Mapping in Refractory Epilepsy Using Magnetoencephalography

Start date: July 14, 2021
Phase:
Study type: Observational

This is a pilot research study where language and working memory tasks will be used to study brain activities from children with epilepsy. Specifically for language assessment, a well-known MEG language protocol will be used and novel signal processing techniques will be applied. A widely utilized paradigm will be used to study memory function and adapt signal-processing techniques from previous literature for the processing and analysis of MEG signals collected during memory task. No treatment/intervention will be performed or evaluated in this pilot research study.

NCT ID: NCT04888624 Completed - Surgical Incision Clinical Trials

A Comparison Between Two Post-operative Dressings

DrySee
Start date: September 13, 2021
Phase: N/A
Study type: Interventional

Surgical site infections are one of the leading causes of post-operative morbidity and mortality worldwide. The ideal post-operative dressing is impermeable and remains intact preventing contamination of the incision with microorganisms. In addition, it is often difficult for the patient to identify breaks in dressing integrity. This trial compares a post-operative dressing (DrySee® Inc. Houston Tx) with moisture detection allowing the patient to recognize when the dressing is compromised to a standard post-operative dressing (Tegaderm® + Pad, 3M, St. Paul, MN). The ideal dressing also allows the patient to shower without removing the dressing.

NCT ID: NCT04888533 Completed - Suicide Risk Clinical Trials

Efficient, Holistic, Heuristic and Semi-structured Suicide Assessment Tool (EHSSA) - Very Accurate Prediction of Risk.

EHSSA
Start date: August 1, 2019
Phase:
Study type: Observational

Many studies have found that insights regarding suicide risk-factors for cohorts does not translate to practical value in the identification of such risk in specific individuals. E.H.S.S.A. - a suicide assessment tool that was empirically designed by an emergency psychiatry department (P.E.S.P. of Bergen County) in its effort to accurately predict, in specific patients, the risk of suicide attempts in the reasonably foreseeable future. It is of a unique paradigm that combines critical elements of holism, heuristics and semi-structured design.

NCT ID: NCT04888494 Completed - Pain Clinical Trials

Hippocampal Stimulation in Chronic Low Back Pain

Start date: June 25, 2021
Phase: N/A
Study type: Interventional

In this study the investigators aim to examine the effects of Transcranial Magnetic Stimulation (TMS) on hippocampal network connectivity and pain levels in individuals with chronic low back pain.

NCT ID: NCT04888377 Completed - Clinical trials for Neurodevelopmental Abnormality

ASPIRIN: Neurodevelopmental Follow-up Trial

Start date: September 1, 2021
Phase:
Study type: Observational

A total of 620 children will be enrolled in this study from six sites in sub-Saharan Africa, South Asia, and Latin America. Half of the children's mothers will have taken aspirin and half will have taken placebo. This will allow the researchers to compare results of the two groups of children and determine if children exposed antenatally to low dose aspirin will have scores on the Bayley Scales of Infant Development-III (BSID-III) examination at 36 months of life (+/-3months) that are not inferior to the child's peers who were not exposed (i.e., by no more than a margin of 4 points).

NCT ID: NCT04888078 Completed - Inguinal Hernia Clinical Trials

Bassini Inguinal Hernia Repair: Obsolete Or Still A Viable Surgical Option?

Start date: January 1, 2006
Phase:
Study type: Observational

Retrospective review of hernia surgery patients at HHMcGuire VAMC focusing on repair type and postoperative complications.

NCT ID: NCT04888000 Completed - Resilience Clinical Trials

Interprofessional Group Intervention to Enhance Compassion Satisfaction and Resilience

CSRS
Start date: April 29, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate an educational professional development program designed to assist health care professionals in developing self-awareness and self-care choices as a means to avoid compassion fatigue and improve resilience.

NCT ID: NCT04887948 Completed - COVID-19 Clinical Trials

Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2

Start date: May 20, 2021
Phase: Phase 3
Study type: Interventional

Study of the safety and immunogenicity of 20vPnC and a booster dose of BNT162b2 administered at the same visit or each vaccine given alone

NCT ID: NCT04887857 Completed - Clinical trials for Leukemia, Myeloid, Acute

A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML)

OMNIVERSE
Start date: December 1, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-486 (ONUREG®) in combination with venetoclax in relapsed and/or refractory Acute Myeloid Leukemia (AML) and newly diagnosed AML.